Columvi combined with gemcitabine and oxaliplatin dramatically extends survival in people with relapsed or refractory diffuse large B-cell lymphoma
The launch of the study was on the occasion of the International Day of Persons with Disabilities
Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
This campaign is to raise awareness about the crucial role helmet usage plays in saving lives
Growing patent filings and tier-2 innovators reflect expanding national research base
Jaypirca is the first and only FDA-approved non-covalent (reversible) BTK inhibitor
The acquisitions merge DatCard and Sorna’s expertise in clinical data sharing with Avandra’s de-identified patient data aggregation platform
Subscribe To Our Newsletter & Stay Updated
